Table 1.
Subcutaneous challenge with WNV NY99 (1000 PFU)# | Intracranial challenge with WNV NY99 (1000 PFU)# | ||||
---|---|---|---|---|---|
Mouse group | % Morbidity (sick/challenged) | % Mortality (dead/challenged) | % Morbidity (sick/challenged) | % Mortality (dead/challenged) | |
PBS | 100 (16/16) | 94 (15/16) | 100 (16/16) | 100 (16/16) | |
WNV Eg101 (1000 PFU) | 0 (0/16) | 0 (0/16) | 0 (0/16) | 0 (0/16) | |
WNV Eg101 (100 PFU) | 0 (0/16) | 0 (0/16) | 0 (0/16) | 0 (0/16) |
* Mice were challenged three-weeks after immunization. # Mice were observed for 21 days after challenge.